Author:
Porreca Angelo,Del Giudice Francesco,Giampaoli Marco,D’Agostino Daniele,Romagnoli Daniele,Corsi Paolo,Del Rosso Alessandro,Maggi Martina,Chung Benjamin I.,Ferro Matteo,de Cobelli Ottavio,Lucarelli Giuseppe,Schiavina Riccardo,De Berardinis Ettore,Sciarra Alessandro,Busetto Gian Maria
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference19 articles.
1. Cancer statistics 2012;Siegel;CA Cancer J Clin,2012
2. Adverse features and competing risk mortality in patients with high-risk prostate cancer;Vagnoni;Clin Genitourin Cancer,2017
3. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate;Dickinson;Eur Urol,2011
4. PCA3 urinary test versus 1H-MRSI and DCEMR in the detection of prostate cancer foci in patients with biochemical alterations;Panebianco;Anticancer Res,2011
5. State of the art of PET/CT with 11-choline and 18F-fluorocholine in the diagnosis and follow-up of localized and locally advanced prostate cancer;Vagnoni;Arch Esp Urol,2015